Literature DB >> 25501805

Full remission in a patient with catheter-associated ventriculitis due to Acinetobacter baumannii treated with intrathecal and intravenous colistin besides coinfections with other multidrug-resistant bacteria.

Rick Dersch1, E Robinson, L Beume, S Rauer, W-D Niesen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25501805     DOI： 10.1007/s10072-014-2031-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  10 in total

1.  Intrathecal use of colistin.

Authors:  W Vasen; P Desmery; S Ilutovich; A Di Martino
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

2.  Clonal spread of meropenem-resistant Acinetobacter baumannii strains in hospitals in the Mediterranean region and transmission to South-west Germany.

Authors:  B Schulte; C Goerke; P Weyrich; S Gröbner; C Bahrs; C Wolz; I B Autenrieth; S Borgmann
Journal:  J Hosp Infect       Date:  2005-10-06       Impact factor: 3.926

3.  Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intrathecal and intravenous colistin.

Authors:  G De Pascale; A Pompucci; R Maviglia; T Spanu; G Bello; A Mangiola; G Scoppettuolo
Journal:  Minerva Anestesiol       Date:  2010-05-06       Impact factor: 3.051

4.  Cure of multiresistant Acinetobacter baumannii central nervous system infections with intraventricular or intrathecal colistin: case series and literature review.

Authors:  John Ng; Iain B Gosbell; John A Kelly; Michael J Boyle; John K Ferguson
Journal:  J Antimicrob Chemother       Date:  2006-08-17       Impact factor: 5.790

5.  Brain penetration of colistin in mice assessed by a novel high-performance liquid chromatographic technique.

Authors:  Liang Jin; Jian Li; Roger L Nation; Joseph A Nicolazzo
Journal:  Antimicrob Agents Chemother       Date:  2009-08-10       Impact factor: 5.191

6.  International study of the prevalence and outcomes of infection in intensive care units.

Authors:  Jean-Louis Vincent; Jordi Rello; John Marshall; Eliezer Silva; Antonio Anzueto; Claude D Martin; Rui Moreno; Jeffrey Lipman; Charles Gomersall; Yasser Sakr; Konrad Reinhart
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

7.  Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments.

Authors:  A Rodríguez Guardado; A Blanco; V Asensi; F Pérez; J C Rial; V Pintado; E Bustillo; M Lantero; E Tenza; M Alvarez; J A Maradona; J A Cartón
Journal:  J Antimicrob Chemother       Date:  2008-02-15       Impact factor: 5.790

Review 8.  Intrathecal colistin for drug-resistant Acinetobacter baumannii central nervous system infection: a case series and systematic review.

Authors:  T Khawcharoenporn; A Apisarnthanarak; L M Mundy
Journal:  Clin Microbiol Infect       Date:  2009-08-17       Impact factor: 8.067

9.  Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin.

Authors:  Yu-Huai Ho; Lih-Shinn Wang; Hui-Jen Chao; Kia-Chich Chang; Chain-Fa Su
Journal:  J Microbiol Immunol Infect       Date:  2007-12       Impact factor: 4.399

Review 10.  Post-neurosurgical multidrug-resistant Acinetobacter baumannii meningitis successfully treated with intrathecal colistin. A new case and a systematic review of the literature.

Authors:  Antonio Cascio; Alfredo Conti; Luca Sinardi; Chiara Iaria; Filippo Flavio Angileri; Giovanna Stassi; Teresa David; Antonio Versaci; Maurizio Iaria; Antonio David
Journal:  Int J Infect Dis       Date:  2009-11-04       Impact factor: 3.623
  10 in total
  2 in total

1.  Evaluation of Intraventricular/Intrathecal Antimicrobial Therapy in the Treatment of Nosocomial Meningitis Caused by Multidrug-Resistant Gram-Negative Bacteria after Central Nervous System Surgery.

Authors:  Nagehan Didem Sari; Sevim Baltali; Istemi Serin; Veysel Antar
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-08-27       Impact factor: 2.471

Review 2.  Spatio-Temporal Distribution of Acinetobacter baumannii in Germany-A Comprehensive Systematic Review of Studies on Resistance Development in Humans (2000-2018).

Authors:  Gamal Wareth; Christian Brandt; Lisa D Sprague; Heinrich Neubauer; Mathias W Pletz
Journal:  Microorganisms       Date:  2020-03-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.